ATI Hematologic Pharmacology Exam

1. A healthcare professional is caring for a patient who has mild hemo- philia A and is about to begin taking desmopressin DDAVP to prevent bleeding the healthcare professional should monitor for which of the following adverse reactions?

2. A healthcare professional is caring for a patient who is about to begin alteplase (Activase) therapy to treat pulmonary embolism. Which of the following drugs should the healthcare professional have available in the event of a severe adverse reaction?

3. A healthcare professional is caring for a patient who is about to begin taking aspirin (Ecotrin) to reduce the risk of a cardiovascular event. The healthcare professional should understand that the drug inhibits platelet aggregation by which of the following mechanisms?

4. A healthcare professional is caring for a patient who is about to begin taking oprelvekin (Neumega). The healthcare professional should explain to the patient that they drug has which of the following effects?

5. I healthcare professional is prepar- ing to administer the prescribed dose of filgrastim (Neupogen) to a patient. The patient's laboratory results indicate that the patient has a white blood count of

12,000 mm3 of the following actions should the healthcare professional tonight?

6. A healthcare professional is caring for a patient who is about to begin taking ferrous sulfate (Feosol) to treat iron-deficiency anemia. When talking with the patient about the drug, the healthcare professional should include which of the following instructions? (Select all that apply.

7. A healthcare professional is caring for a patient who is about to begin iron dextran (INFed) therapy. When administering the drug IM, the healthcare professional should take which of the following actions? (Select all that apply.)

8. A patient is about to begin therapy with recombi- nant factor IX (BeneFix) to treat hemophilia B. The patient asks the health care professional about the risk of disease transmission with recombinant factor IX, as compared with plasma-derived factor IX. The health care professional should explain that recombinant factor IX illuminates the risk for which of the following?

 9. A healthcare professional is caring for a patient who is about to begin alteplase (Activase) therapy. The health care professional should monitor the patient for which of the following indications of the possible adverse effect?

10. A healthcare professional is caring for a patient who is about to begin taking epoetin alfa (Epogen). Which of the following laboratory values should increase with effective therapy?

11. A healthcare professional ask- ing for a patient who is about to begin taking oprelvekin (Neumega) to treat thrombocytopenia. The healthcare professional should tell the patient to report which of the following indications of an adverse reaction? (Select all that apply.)

12. A patient who is taking ferrous sulfate (Feosol) to treat iron-deficiency anemia develop severe nausea and vomiting due to iron toxicity. Which of the following drugs should a healthcare professional use to treat this complication?

13. A patient who is taking warfarin (Coumadin) arrives to the emer- gency department and reports rectal bleeding. Which of the following drugs should healthcare professional have available?

14.  A healthcare professional should assess a patient who has megaloblastic anemia for indications of which of the following vitamin deficiencies?

15. A healthcare professional is caring for a patient who is about to begin taking (Plavix) to prevent thrombus formation. The healthcare professional should question the use of clopidogrel by a patient who has which of the following?

16. A healthcare professional is caring for a patient who is about to begin taking warfarin (Coumadin). The healthcare professional should caution the patient about taking which of the following over-the-counter drugs?

17. A healthcare professional administers epoetin alpha (Epogen) subcutaneously to patient who has renal failure. The healthcare professional should monitor the patient for which of the following adverse effects?

18. A healthcare professional is caring for a patient who is about to begin taking folic acid to treat megaloblastic anemia. The healthcare professional should monitor which of the following laboratory values?

19. A healthcare professional is caring for a patient who is undergoing bone marrow transplant patient following high-dose chemotherapy which of the following drug should a healthcare professional expect the primary care provider to prescribe to reduce the patient's risk of infection?

 20. A healthcare professional is caring for a patient who has a known sensitivity to E. coli derived proteins. This sensitivity is a contraindi- cation for which of the following drugs?

21.  A healthcare professional is admin- istering epoetin alpha (Epogen) subcutaneously to patient has renal failure. The healthcare professional should take which of the following actions?

22. A healthcare professional is caring for a patient who is about to begin taking alteplase (Activase) to treat acute myocardial infarction. The healthcare professional should understand the drug is most effective when the patient receives it...

23. A healthcare professional is caring for a patient who is about to begin factor VIII (Advate) therapy to treat hemophilia A. When administering factor VIII, which of the following actions should the healthcare professional take?

24. A healthcare professional is caring for a patient who is about to begin taking filgrastim (Neupogen) to treat neutropenia. The healthcare professional should assess the patient for which of the following adverse effects?

25. A healthcare professional is caring for a patient who is about to begin taking clopidogrel (Plavix) to prevent stent stenosis. The healthcare professional should monitor the patient for which of the following adverse reac- tions?